Cargando…

Serum Uric Acid and Nigral Iron Deposition in Parkinson’s Disease: A Pilot Study

BACKGROUND: Uric acid (UA) is an endogenous antioxidant which is known to reduce oxidative stress and also chelate iron ion. Recent studies have provided evidence that UA may play a neuroprotective role in Parkinson’s disease (PD). However, it is unknown whether UA relates to nigral iron deposition,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae-Hyoung, Lee, Jae-Hyeok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227693/ https://www.ncbi.nlm.nih.gov/pubmed/25386854 http://dx.doi.org/10.1371/journal.pone.0112512

Ejemplares similares

Novel Pattern of Iron Deposition in the Fascicula Nigrale in Patients with Parkinson's Disease: A Pilot Study
por: Peckham, Miriam E., et al.
Publicado: (2016)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

Nigral iron deposition in common tremor disorders
por: Homayoon, Nina, et al.
Publicado: (2018)

Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks
por: Wen, Jiaqi, et al.
Publicado: (2022)

Genetic impacts on nigral iron deposition in Parkinson's disease: A preliminary quantitative susceptibility mapping study
por: Wu, Jingjing, et al.
Publicado: (2023)

Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s disease
por: Langley, Jason, et al.
Publicado: (2021)

Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
por: Jellen, Leslie C., et al.
Publicado: (2021)

Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration
por: Ayton, Scott, et al.
Publicado: (2014)

Height and nigral neuron density in Parkinson’s disease
por: Saari, Laura, et al.
Publicado: (2022)

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
por: Ayton, Scott, et al.
Publicado: (2014)

Asymmetrical nigral iron accumulation in Parkinson’s disease with motor asymmetry: an explorative, longitudinal and test-retest study
por: Guan, Xiaojun, et al.
Publicado: (2020)

Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson’s Disease
por: Scholten, Marlieke, et al.
Publicado: (2017)

Reversing Parkinson Disease Model with in situ Converted Nigral Neurons
por: Qian, Hao, et al.
Publicado: (2020)

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson’s disease
por: Pflug, Christina, et al.
Publicado: (2020)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Nigral volume loss in prodromal, early, and moderate Parkinson’s disease
por: Langley, Jason, et al.
Publicado: (2023)

Serum uric acid levels in Parkinson's disease and related disorders
por: Sakuta, Hideki, et al.
Publicado: (2016)

Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson’s Disease: A Case-Control Study
por: Songsomboon, Chayanon, et al.
Publicado: (2020)

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson’s disease
por: Hernadi, Gabriella, et al.
Publicado: (2021)

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
por: Sian-Hulsmann, Jeswinder, et al.
Publicado: (2021)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease
por: Simunovic, Filip, et al.
Publicado: (2010)

Comparison of Shod and Unshod Gait in Patients With Parkinson's Disease With Subthalamic and Nigral Stimulation
por: Horn, Martin A., et al.
Publicado: (2022)

Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
por: Schröter, Nils, et al.
Publicado: (2022)

Serum uric acid levels in patients with Parkinson’s disease: A meta-analysis
por: Wen, Min, et al.
Publicado: (2017)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
por: Soares, Nayron Medeiros, et al.
Publicado: (2023)

Association of Renal Manifestations with Serum Uric Acid in Korean Adults with Normal Uric Acid Levels
por: Jung, Dong-Hyuk, et al.
Publicado: (2010)

The Clinical Significance of Uric Acid Deposits
por: Campbell, F. R.
Publicado: (1887)

Level of uric acid and uric acid/creatinine ratios in correlation with stage of Parkinson disease
por: Zhong, Ling-Ling, et al.
Publicado: (2018)

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene
por: Labandeira‐Garcia, Jose L., et al.
Publicado: (2022)

The Effects of Uric Acid, Serum Vitamin D3, and Their Interaction on Parkinson's Disease Severity
por: Meamar, Rokhsareh, et al.
Publicado: (2015)

A Review of Uric Acid, Crystal Deposition Disease, and Gout
por: Perez-Ruiz, Fernando, et al.
Publicado: (2014)

The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome
por: Yu, Tae Yang, et al.
Publicado: (2019)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial
por: Weiss, Daniel, et al.
Publicado: (2013)

Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease
por: Chalazonitis, Alcmène, et al.
Publicado: (2022)

An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
por: Hua, Ye, et al.
Publicado: (2023)

Altered Serum Uric Acid Levels in Kidney Disorders
por: Kim, Gheun-Ho, et al.
Publicado: (2022)

Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review
por: Boonstra, Jackson Tyler, et al.
Publicado: (2022)

Uric acid and cardiometabolic diseases
por: Lee, Seung Jae, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f2453s65q9ledm0mgsa0m1116r